The heath economic value of aspirin in the primary prevention of cardiovascular disease in diabetic patients

被引：0

作者：

Moeremans, K. ^{[1
]}

Lamotte, M. ^{[1
]}

Wittrup-Jensen, K. ^{[2
]}

Pignone, M. ^{[3
]}

机构：

[1] IMS Hlth, Brussels, Belgium

[2] Bayer Schering Pharma, Berlin, Germany

[3] Univ N Carolina, Chapel Hill, NC USA

来源：

EUROPEAN HEART JOURNAL | 2009年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：233 / 233

页数：1

共 50 条

[1] The health economic value of Aspirin in the primary prevention of cardiovascular disease in diabetic patients in four European countries
Kubin, M
Lamotte, M
Annemans, L
Evers, T
DIABETOLOGIA, 2005, 48 : A331 - A331
[2] The Health Economic Value of Aspirin in the Primary Prevention of Cardiovascular Disease in Diabetic Patient's
Moeremans, Karen
Lamotte, Mark
Wittrup-Jensen, Kim U.
Pignone, Michael
DIABETES, 2009, 58 : A12 - A12
[3] Aspirin in the primary prevention of cardiovascular disease in hypertensive patients - The health economic perspective
Lamotte, M
Annemans, L
Evers, T
Kubin, M
AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 225A - 225A
[4] Aspirin in the primary prevention of cardiovascular disease - The health economic perspective
Lamotte, M
Annemans, L
Evers, T
Kubin, M
ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 143 - 143
[5] Aspirin in the primary prevention of cardiovascular disease - the health economic perspective
Lamotte, M.
Annemans, L.
Kubin, M.
Evers, T.
EUROPEAN HEART JOURNAL, 2005, 26 : 582 - 583
[6] A health economic evaluation of aspirin in the primary prevention of cardiovascular disease
Lamotte, M
Annemans, L
Evers, T
Kubin, M
VALUE IN HEALTH, 2004, 7 (06) : 637 - 637
[7] Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation
Annemans, L.
Lamotte, M.
Kubin, M.
Evers, T.
Verheugt, F. W. A.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (09) : 1129 - 1137
[8] Aspirin in the primary prevention of cardiovascular disease in Italian hypertensive patients - The health economic perspective
Lamotte, M
Annemans, L
Evers, T
Kubin, M
JOURNAL OF HYPERTENSION, 2005, 23 : S168 - S168
[9] Aspirin in the primary prevention of cardiovascular disease
Galloway, Colin F.
Stevenson, John C.
MATURITAS, 2011, 68 (01) : 3 - 4
[10] A health-economic evaluation of aspirin: Primary prevention and cardiovascular disease
Sakai, Takaaki
Saku, Keijiro
INTERNAL MEDICINE, 2007, 46 (08) : 431 - 433

← 1 2 3 4 5 →